#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Ewing's sarcoma recurrent Cystic fibrosis Thalassaemia beta Epileptic encephalopathy Allogenic stem cell transplantation Chronic cutaneous lupus erythematosus Neuropathic arthropathy Round cell liposarcoma Palmoplantar pustulosis Sickle cell disease Meningitis meningococcal Immune-mediated renal disorder Immunodeficiency Lung adenocarcinoma More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Trials in Disease KBG syndrome Primary biliary cholangitis – Basic Information Mastocytosis – Life with Disease Lymphangiosarcoma – Life with Disease Turner’s syndrome – Treatment Von Willebrand’s disease – Basic Information Pelizaeus-Merzbacher disease – Trials in Disease Congenital hypotransferrinaemia – Life with Disease Glomerulonephritis membranous – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TUB-030 Linagliptin Isoleucine Alxn1850 PIROXICAM Latanoprost Zamtocabtagene Autoleucel Lutropin Alfa Resatorvid Dsimc Lixudebart Cusatuzumab Vibostolimab Nomegestrol Acetate Pioglitazone Hydrochloride Calcifediol Danicopan Dog Epithelium Extract Sodium Butyrate Iodixanol More therapies…

    Learn about Your Condition

    Diabetic nephropathy Bladder cancer stage II Alveolar rhabdomyosarcoma Neonatal anoxia Bronchiolitis Magnetic resonance imaging Tendon injury Premature baby Chronic hepatitis B Arterial stiffness PIK3CA-activated mutation Fatty acid oxidation disorder Oesophagogastroscopy Oral herpes Pseudomyxoma peritonei More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain

  • Study of flortaucipir and florbetapir in patients with memory disorders including Alzheimer’s disease and dementia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetapir (18F)
    • Flortaucipir (18F)
    France

  • Study of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Morphine Sulfate
    • Nefopam
    France

  • A study of estradiol and progesterone treatment for blood sugar control in women with type 1 or type 2 diabetes during or after menopause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopause
    • Diabetes mellitus
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • Testing bifikafusp alfa and onfekafusp alfa injections in patients with locally advanced basal cell carcinoma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain

  • Study of bifikafusp alfa and onfekafusp alfa injected into tumors for patients with locally advanced basal cell carcinoma who progressed on or cannot tolerate systemic treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain
Previous Page
1 … 81 82 83 84 85 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!